Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Janos L. Tanyi, MD, PhD

Janos L. Tanyi, MD, PhD Surgeon

Assistant Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Languages spoken:

  • Hungarian

Dr. Tanyi is employed by Penn Medicine.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Gynecologic Oncology

Programs & Centers:

Board Certification:

  • ObGyn/GynecologicOncology (AMA)
  • Obstetrics and Gynecology, 2010

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Cervical Lesions
  • Cervix Biopsy
  • Chemotherapy for Gynecologic Cancers
  • Colposcopy
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Cancer
  • Gynecologic Cancer Surgery
  • Gynecologic Surgery
  • Gynecology Clinical Trials
  • Hysterectomy (Uterus Surgery)
  • Hysteroscopy
  • Laparoscopic Hysterectomy
  • Laparoscopic Supracervical Hysterectomy
  • Laparoscopic Surgery
  • Laparoscopy
  • Loop Electrosurgical Excision Procedure (LEEP)
  • Minimally Invasive Hysterectomy
  • Ovarian Cancer
  • Robotic Surgery
  • Trophoblastic Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University Medical School of Debrecen
Residency: Semmelweis University, Medical School
Residency: Baylor College of Medicine - Ben Taub General Hospital
Fellowship: Hospital of the University of Pennsylvania

Memberships

Fellow, American College of Obstetrics and Gynecology, National Inactive member, European Association of Gynecologists and Obstetricians, International

Hospital Affiliation

Dr. Tanyi is employed by Penn Medicine.

Hospital Privileges:

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Lorenzo Ramirez, A. T. Charlie Johnson, Cindy Otto, Janos Laszlo Tanyi, Jody Piltz-Seymour, Jae Hyock Kwak, Katharine Prigg, Nicholas Kybert, George Preti; California Lutheran University, Thousand Oaks, CA; University of Pennsylvania Department of Physics & Astronomy, Philadelphia, PA; University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA; University of Pennsylvania, Philadlephia, PA; University of Pennsylvania Perelman School of Medicine, Narberth, PA; Global Spectroscopy 2, Teterboro: Exploring ovarian cancer detection using an interdisciplinary investigation of its volatile odor signature, 2018 ASCO Annual Meeting, Chicago, : 2018.

Tanyi JL, Bobisse S, Ophir E, Tuyaerts S, Roberti A, Genolet R, Baumgartner P, Stevenson BJ, Iseli C, Dangaj D, Czerniecki B, Semilietof A, Racle J, Michel A, Xenarios I, Chiang C, Monos DS, Torigian DA, Nisenbaum HL, Michielin O, June CH, Levine BL, Powell DJ Jr, Gfeller D, Mick R, Dafni U, Zoete V, Harari A, Coukos G, Kandalaft LE.: Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer Sci Transl Med. : 10(436). ,2018.

Katsnelson M, Hwang WT, Tahirovic E, Rubin SC, Tanyi JL.: Preoperative predictors that impact the survival and outcome of patients undergoing secondary cytoreduction for ovarian cancer. J Obstet Gynaecol : 38(3):395-401,2018.

Bobisse S, Genolet R, Roberti A, Tanyi JL, Racle J, Stevenson BJ, Iseli C, Michel A, Le Bitoux MA, Guillaume P, Schmidt J, Bianchi V, Dangaj D, Fenwick C, Derré L, Xenarios I, Michielin O, Romero P, Monos DS, Zoete V, Gfeller D, Kandalaft LE, Coukos G, Harari A.: Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer. Nat Commun : 9(1):1092,2018.

Uribe-Herranz M, Bittinger K, Rafail S, Guedan S, Pierini S, Tanes C, Ganetsky A, Morgan MA, Gill S, Tanyi JL, Bushman FD, June CH, Facciabene A.: Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12. JCI Insight : 3(4),2018.

O'Hara MH, Stashwick C, Plesa G, Tanyi JL: Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers. Immunotherapy 9(9):767-80 : 2017.

O'Hara MH, Stashwick C, Plesa G, Tanyi JL.: Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers. Immunotherapy : 9(9):767-780,2017.

Yang L, Zhang Y, Shan W, Hu Z, Yuan J, Pi J, Wang Y, Fan L, Tang Z, Li C, Hu X, Tanyi JL, Fan Y, Huang Q, Montone K, Dang CV, Zhang L: Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition. Sci Transl Med 9(400) : 2017.

Tanyi JL, Stashwick C, Plesa G, Morgan MA, Porter D, Maus MV, June CH: Possible compartmental cytokine release syndrome in a patient with recurrent ovarian cancer after treatment with Mesothelin-targeted CAR-T cells. J Immunother 40(3):104-10 : 2017.

Randall L, Wenham RN, Dowdy SC, Low P, Tanyi JL: A Phase 2, Single-Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer. SGO 48th Annual Meeting on Women's Cancer. Scientific Plenary Session, Annual Meeting, National Harbor, MD, : 2017.

Academic Contact Info

University of Pennsylvania Health System,
Department of Obstetrics and Gynecology
Jordan Center for Gynecologic Cancer at Penn
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard, 3 West

Philadelphia, PA 19104
Phone: (215) 662-3318
Patient appointments: 800-789-7366 (PENN)